Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhengqi tablet
- Development stage
- Unknown
- Lead developer
- Shuguang Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Zhengqi tablet is a Traditional Chinese Medicine (TCM) hospital preparation developed by Shuguang Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine, specifically for the prevention and treatment of COVID-19. Approved by the Shanghai Medical Products Administration during the 2022 Omicron outbreak, the formulation is designed to invigorate qi, resolve dampness, and detoxify. It is composed of several herbal ingredients, including *Astragalus membranaceus*, *Atractylodes macrocephala*, *Saposhnikovia divaricata*, and *Pogostemon cablin*. The tablet is primarily used to enhance the body's immune defense (Zheng Qi) and mitigate symptoms in patients with mild COVID-19 or those in recovery. Its mechanism of action involves a multi-component, multi-target approach that includes immunomodulation of cytokine levels and potential interference with viral entry and replication pathways.
- Brand names
- Zhengqi tablet
- Other names
- Zhengqi PianShuguang Zhengqi Tablet
02
Targets
ACE2 (Angiotensin-converting enzyme 2)IL-6 (Interleukin 6)3CLpro (3C-like proteinase)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on Zhengqi tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhengqi tablet.